Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalMarket CapitalizationReturn on AssetsReturn on Capital EmployedReturn on Equity

Benitec Biopharma (BNTC) Operating Margin: 2019-2023

Historic Operating Margin for Benitec Biopharma (BNTC) over the last 2 years, with Jun 2023 value amounting to -65,000.00%.

  • Benitec Biopharma's Operating Margin was N/A to -65,000.00% in Q2 2023 from the same period last year, while for Jun 2023 it was -15,513.01%, marking a year-over-year change of. This contributed to the annual value of -25,441.33% for FY2023, which is 98380.00% down from last year.
  • Latest data reveals that Benitec Biopharma reported Operating Margin of -65,000.00% as of Q2 2023, which was down 708.57% from -8,038.89% recorded in Q1 2023.
  • In the past 5 years, Benitec Biopharma's Operating Margin registered a high of 8,248.57% during Q2 2020, and its lowest value of -379,300.00% during Q1 2021.
  • In the last 3 years, Benitec Biopharma's Operating Margin had a median value of -40,071.43% in 2022 and averaged -101,672.66%.
  • Its Operating Margin has fluctuated over the past 5 years, first crashed by 37,176,071bps in 2021, then soared by 37,209,167bps in 2022.
  • Quarterly analysis of 5 years shows Benitec Biopharma's Operating Margin stood at -2,741.56% in 2019, then tumbled by 32,315,844bps to -325,900.00% in 2020, then skyrocketed by 30,656,000bps to -19,340.00% in 2021, then slumped by 2,073,143bps to -40,071.43% in 2022, then tumbled by 83,056bps to -65,000.00% in 2023.
  • Its last three reported values are -65,000.00% in Q2 2023, -8,038.89% for Q1 2023, and -40,071.43% during Q4 2022.